141 related articles for article (PubMed ID: 5936944)
1. An evaluation of vasodilator drugs in occlusive vascular disease by measurement.
Gillespie JA
Angiology; 1966 May; 17(5):280-8. PubMed ID: 5936944
[No Abstract] [Full Text] [Related]
2. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
Dabizzi RP; Fantini F; Cappelli G; Grandonico F
Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
[No Abstract] [Full Text] [Related]
3. Practical impact of hemorheology on the treatment of chronic peripheral ischemia.
Dormandy JA
Angiology; 1981 Oct; 32(10):710-4. PubMed ID: 7325406
[No Abstract] [Full Text] [Related]
4. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
Giulini SM; Agus GB; De Cristoforo A
Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
[No Abstract] [Full Text] [Related]
5. Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders.
Lowe GD
Br Med J (Clin Res Ed); 1983 Apr; 286(6373):1262-4. PubMed ID: 6404416
[No Abstract] [Full Text] [Related]
6. Vasodilator drugs and peripheral vascular disease.
Drug Ther Bull; 1972 Nov; 10(23):91-2. PubMed ID: 4144248
[No Abstract] [Full Text] [Related]
7. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
[No Abstract] [Full Text] [Related]
8. Vasodilator drugs in peripheral vascular disease.
Coffman JD
J Maine Med Assoc; 1975 Oct; 66(10):262-9. PubMed ID: 1104731
[No Abstract] [Full Text] [Related]
9. Medical treatment of peripheral vascular disease: good or bad?
Duprez D; Clement DL
Eur Heart J; 1992 Feb; 13(2):149-51. PubMed ID: 1555609
[TBL] [Abstract][Full Text] [Related]
10. [Can the Doppler method indicate the usefulness of vasodilator therapy?].
Bartolo M; Antignani PL
Recenti Prog Med; 1981 Aug; 71(2):175-84. PubMed ID: 7313287
[No Abstract] [Full Text] [Related]
11. [Experiences with the new vasotherapeutic drug Trental in dermatology].
Herger R
Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
[No Abstract] [Full Text] [Related]
12. [Effect of nicotinate of xanthinol prolongatum on the walking distance of patients with arterial insufficiency of the lower extremities].
Joos F; Basyn M; Rocher A
Acta Clin Belg; 1972; 27(5):529-47. PubMed ID: 4669777
[No Abstract] [Full Text] [Related]
13. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
Coscia M
Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
[No Abstract] [Full Text] [Related]
14. Cyclospasmol in peripheral and cerebral vascular disease.
Med Lett Drugs Ther; 1967 Jan; 9(3):9-10. PubMed ID: 6031272
[No Abstract] [Full Text] [Related]
15. Peripheral vasodilator drugs.
Br Med J; 1969 Jul; 3(5661):38-40. PubMed ID: 5787285
[No Abstract] [Full Text] [Related]
16. Responsiveness of various symptoms of vascular disorders to calcium antagonist.
Verhaegen H; Reyntjens A; Horig C; Pötsch W
Angiology; 1979 Jul; 30(7):447-53. PubMed ID: 380409
[No Abstract] [Full Text] [Related]
17. The effect of nicotinic acid on muscle blood flow in intermittent claudication measured with xenon-133 clearance method.
Broomé A; Cederlund J; Eklöf B
Scand J Clin Lab Invest Suppl; 1967; 99():233-40. PubMed ID: 4862835
[No Abstract] [Full Text] [Related]
18. Phosphorus magnetic resonance spectroscopy: a noninvasive technique for the study of occlusive arterial leg disease and peripheral vasodilator therapy.
Wahl DG; Simon JP; Robin B; Walker P; Jouanny P; Escanye JM; Paille F; Schmidt C; Brunotte F; Robert J
Angiology; 1994 May; 45(5):367-76. PubMed ID: 8172384
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of various vasodilator agents by measuring the isotopic peripheral flow].
Spach MO; Schwartz J
Therapie; 1977; 32(3):301-8. PubMed ID: 337564
[No Abstract] [Full Text] [Related]
20. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
Bock KJ
Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
[No Abstract] [Full Text] [Related]
[Next] [New Search]
